Trials / Completed
CompletedNCT04708795
Clinical Trial on Pharmacokinetic and Tolerability of AP701
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- CannaXan GmbH · Industry
- Sex
- Male
- Age
- 35 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This study aims to investigate the uptake of AP701, a preparation from cannabis flowers, into the bloodstream after in single administration in healthy volunteers.
Detailed description
Pharmacokinetic parameters and tolerability of AP701 is studied over 30 hours after single dose administration in healthy volunteers in a prospective and open-label manner at a single study center.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AP701 | Preparation of Cannabis flowers (Cannabis flos) |
Timeline
- Start date
- 2020-01-11
- Primary completion
- 2021-03-07
- Completion
- 2021-03-07
- First posted
- 2021-01-14
- Last updated
- 2021-03-10
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04708795. Inclusion in this directory is not an endorsement.